Please use this identifier to cite or link to this item: https://dspace.ctu.edu.vn/jspui/handle/123456789/55095
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHo, Thi Bich Phuong-
dc.contributor.authorVien, Ngoc Thach-
dc.contributor.authorLuong, Hoang Ngan-
dc.contributor.authorLe, Thi Truc Linh-
dc.date.accessioned2021-06-15T07:59:43Z-
dc.date.available2021-06-15T07:59:43Z-
dc.date.issued2018-
dc.identifier.issn1859-3453-
dc.identifier.urihttps://dspace.ctu.edu.vn/jspui/handle/123456789/55095-
dc.description.abstractMicroRNAs are short endogenous non-coding RNA molecules, typically 19-25 nucleotides in length, which negatively regulate gene expression through binding to 3’UTR of target mRNAs, leading to repression of protein translation or target mRNA degradation. MicroRNA-144 (miR-144) was found as an abnormal expression in various diseases, including osteoarthritis (OA). We have identified increased microRNA-144 expression in early phase and end stage of OA. However, the molecular mechanism of this increase has not been yet to be determined yet. Using bioinformatics tools, we found more than 4,000 mRNAs that are predicted to be potential direct targets of miR-144, including mRNAs involved in the critical signaling pathways in OA e.g. TGF(3/Smad2/3 and WNT/p-catenin. Results from this research provide information for future ex periments to validate miR-144 potential targets.vi_VN
dc.language.isoenvi_VN
dc.relation.ispartofseriesJournal of Science HCM Open University;Vol. 8 No. 01 .- P.36-44-
dc.subjectBioinformaticsvi_VN
dc.subjectMicroRNA-144vi_VN
dc.subjectOsteoarthritisvi_VN
dc.titleUsing bioinformatics to predict potential targets of microrna-144 in osteoarthritisvi_VN
dc.typeArticlevi_VN
Appears in Collections:Khoa học Trường ĐH Mở Tp.HCM (Journal of Science HCM Open University)

Files in This Item:
File Description SizeFormat 
_file_
  Restricted Access
493.25 kBAdobe PDF
Your IP: 3.138.134.149


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.